Moreover, in KEGG analysis, the upregulated robust DEGs were significantly enriched in the cell cycle, pathways in cancer, and the PI3K-Akt signaling pathway (Figure 3(d)), and the downregulated robust DEGs were significantly enriched in pathways in cancer, HTLV-I infection, and focal adhesions (Figure 3(h)). This evidence concerns the gene AKT1 and cancer.